prostatic_involvement_percent,treatment_effect_indicator,tumor_code_id,days_to_pathology_detail,intron,days_to_diagnosis,initial_weight,hpv_positive_type,undescended_testis_history_laterality,environmental_tobacco_smoke_exposure,therapeutic_levels_achieved,risk_factor_method_of_diagnosis,percent_normal_cells
0,No,1,0,intron-1,0,45.2,26,Bilateral,No,No,Biochemical Assessment,98.5
5,Not Reported,4,1,intron-2,7,30.5,33,Left,Unknown,Not Reported,Both Clinical and Biochemical Assessments,95.2
10,Unknown,20,3,intron-3,14,55.8,35,Not Reported,Yes,Unknown,Clinical Assessment,87.0
15,Yes,40,5,intron-4,30,60.1,39,Right,No,Yes,Not Reported,76.3
20,Not Reported,41,7,intron-5,45,25.4,45,Left,Unknown,Yes,Both Clinical and Biochemical Assessments,82.1
25,Not Reported,50,10,intron-6,60,35.7,51,Not Reported,Yes,No,Clinical Assessment,69.4
30,Not Reported,51,14,intron-7,90,40.3,53,Bilateral,Yes,Unknown,Both Clinical and Biochemical Assessments,55.8
35,Not Reported,52,21,intron-8,120,50.6,59,Bilateral,Unknown,Yes,Clinical Assessment,49.6
40,Not Reported,60,28,intron-9,150,65.9,68,Left,Unknown,No,Both Clinical and Biochemical Assessments,33.7
45,Not Reported,71,35,intron-10,180,70.0,Other,Bilateral,Yes,No,Biochemical Assessment,25.4
50,Not Reported,41,42,intron-11,210,75.3,51,Left,Yes,Unknown,Clinical Assessment,18.9
55,Not Reported,41,49,intron-12,240,80.6,33,Not Reported,No,Not Reported,Clinical Assessment,12.5
60,Not Reported,41,56,intron-13,270,85.1,53,Bilateral,Yes,Not Reported,Clinical Assessment,7.2
75,Not Reported,41,63,intron-14,300,90.4,51,Bilateral,No,No,Clinical Assessment,4.8
90,Not Reported,1,70,intron-15,365,95.7,Other,Left,No,No,Both Clinical and Biochemical Assessments,1.3
